JPMorgan Chase & Co’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-459,229
| Closed | -$8.93M | – | 4970 |
|
|
2018
Q1 | $8.93M | Buy |
459,229
+81,430
| +22% | +$1.58M | ﹤0.01% | 1839 |
|
|
2017
Q4 | $6.29M | Buy |
377,799
+71,937
| +24% | +$1.2M | ﹤0.01% | 2091 |
|
|
2017
Q3 | $6.46M | Sell |
305,862
-88,875
| -23% | -$1.88M | ﹤0.01% | 2035 |
|
|
2017
Q2 | $6.36M | Sell |
394,737
-130,496
| -25% | -$2.1M | ﹤0.01% | 1998 |
|
|
2017
Q1 | $6.64M | Buy |
525,233
+49,252
| +10% | +$623K | ﹤0.01% | 1933 |
|
|
2016
Q4 | $6.31M | Buy |
475,981
+384,106
| +418% | +$5.09M | ﹤0.01% | 1976 |
|
|
2016
Q3 | $2.18M | Buy |
91,875
+5,670
| +7% | +$134K | ﹤0.01% | 2423 |
|
|
2016
Q2 | $2.48M | Buy |
86,205
+14,008
| +19% | +$404K | ﹤0.01% | 2356 |
|
|
2016
Q1 | $2.31M | Sell |
72,197
-19,399
| -21% | -$621K | ﹤0.01% | 2315 |
|
|
2015
Q4 | $3.92M | Sell |
91,596
-7,839
| -8% | -$335K | ﹤0.01% | 2067 |
|
|
2015
Q3 | $3.5M | Buy |
99,435
+2,016
| +2% | +$71K | ﹤0.01% | 2129 |
|
|
2015
Q2 | $4.47M | Sell |
97,419
-22,707
| -19% | -$1.04M | ﹤0.01% | 2143 |
|
|
2015
Q1 | $5.63M | Sell |
120,126
-208,900
| -63% | -$9.79M | ﹤0.01% | 2032 |
|
|
2014
Q4 | $10.4M | Sell |
329,026
-102,577
| -24% | -$3.25M | ﹤0.01% | 1666 |
|
|
2014
Q3 | $10.2M | Sell |
431,603
-85,698
| -17% | -$2.03M | ﹤0.01% | 1655 |
|
|
2014
Q2 | $15.5M | Buy |
517,301
+287,170
| +125% | +$8.61M | ﹤0.01% | 1461 |
|
|
2014
Q1 | $6.08M | Sell |
230,131
-350,326
| -60% | -$9.26M | ﹤0.01% | 1941 |
|
|
2013
Q4 | $14.6M | Buy |
580,457
+23,634
| +4% | +$594K | ﹤0.01% | 1442 |
|
|
2013
Q3 | $11.4M | Sell |
556,823
-90,245
| -14% | -$1.85M | ﹤0.01% | 1586 |
|
|
2013
Q2 | $12.9M | Buy |
+647,068
| New | +$12.9M | ﹤0.01% | 1415 |
|